Table 1.
Baseline characteristics of the analyzed participants in the general population
| HC | pre-MetS | MetS | Overall | p valuea | |
|---|---|---|---|---|---|
| Number (%) | 2,274 (16.8) | 7,776 (57.4) | 3,504 (25.9) | 13,554 (100.0) | <0.001 |
| Obesity (%) | 0 (0.0) | 2,754 (35.4) | 2,976 (84.9) | 5,730 (42.3) | <0.001 |
| Hypertension (%) | 0 (0.0) | 4,714 (60.6) | 3,292 (93.9) | 8,006 (59.1) | <0.001 |
| Hyperglycemia (%) | 0 (0.0) | 1,816 (23.4) | 2,434 (69.5) | 4,250 (31.4) | <0.001 |
| Dyslipidemia (%) | 0 (0.0) | 2,411 (31.0) | 2,732 (78.0) | 5,143 (37.9) | <0.001 |
| Male (%) | 1,064 (46.8) | 3,651 (47.0) | 1,649 (47.1) | 6,364 (47.0) | 0.98 |
| Age, mean (SD) | 67.01 (5.85) | 67.88 (5.99) | 68.29 (5.66) | 67.84 (5.90) | <0.001 |
| BMI, mean (SD) | 21.69 (2.11) | 24.26 (2.98) | 27.15 (2.86) | 24.58 (3.34) | <0.001 |
| TC, mean (SD) | 4.77 (0.72) | 4.92 (0.95) | 4.96 (1.05) | 4.91 (0.94) | <0.001 |
| GLU, mean (SD) | 5.10 (0.52) | 5.78 (1.59) | 7.16 (2.28) | 6.02 (1.83) | <0.001 |
| HDLC, mean (SD) | 1.56 (0.38) | 1.40 (0.36) | 1.27 (0.38) | 1.39 (0.38) | <0.001 |
| LDLC, mean (SD) | 2.75 (0.63) | 2.93 (0.82) | 2.97 (0.87) | 2.91 (0.81) | <0.001 |
| TGs, mean (SD) | 1.02 (0.31) | 1.58 (1.04) | 2.44 (1.62) | 1.71 (1.24) | <0.001 |
| UA, mean (SD) | 302.44 (70.21) | 333.46 (83.11) | 362.62 (86.86) | 335.80 (84.35) | <0.001 |
HC, healthy control; pre-MetS, pre-metabolic syndrome; MetS, metabolic syndrome; SD, standard deviation; BMI, body mass index; TC, serum total cholesterol; GLU, glucose; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; TGs, triglycerides; UA, uric acid.
a
p values calculated by χ2 tests for categorical data and one-way analysis of variance for parametric data.